Patent · US Expired

14.alpha., 17.alpha.-ethano-16.alpha.-hydroxy-estratrienes

US5529993A · kind A · utility

0Cited by
1References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 29, 1990
Grant dateJun 25, 1996
Priority date
Expiry dateNov 29, 2010

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P5/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A 14.alpha.,17.alpha.-bridged estratriene of formula I ##STR1## wherein (a) OR.sup.3 is in .alpha.-position PA1 R.sup.1, R.sup.2 and R.sup.3, each independently are (i) hydrogen, (ii) ##STR2## in which R.sup.4 is an organic radical with up to 11 carbon atoms or (iii) --(CH.sub.2).sub.n COOH wherein n=1-4, or (iv) R.sup.1 is a benzyl, C.sub.1 -C.sub.8 alkyl or C.sub.3 -C.sub.5 cycloalkyl, or PA1 (b) OR.sup.3 is in .beta.-position PA1 R.sup.1, R.sup.2 and R.sup.3, each independently are (i) hydrogen, (ii) an acyl group with 1 to 12 carbon atoms or (iii) R.sup.1 is C.sub.1 -C.sub.8 alkyl, and in both (a) and (b) A--B is an etheno or ethano bridge.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.